Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stijn Vansteelandt

Showing results (51-60 of 184) with videos related to

Pageof 19
Sort By:
Statistics in Medicine|December 6, 2014
Increasing the power of the Mann-Whitney test in randomized experiments through flexible covariate adjustmentKarel Vermeulen, Olivier Thas, Stijn Vansteelandt
Pharmacoepidemiology and Drug Safety|November 26, 2025
All Lines Is the Right Approach: Selecting Patient Lines of Therapy for an External Comparator ArmDaniel Backenroth, Laura Hester, Stijn Vansteelandt
Epidemiology (Cambridge, Mass.)|February 6, 2019
Adjusting the Effect of Integrating Antiretroviral Therapy and Tuberculosis Treatment on Mortality for Noncompliance: A Time-varying Instrumental Variables AnalysisNonhlanhla Yende-Zuma, Henry Mwambi, Stijn Vansteelandt
Statistics in Medicine|May 12, 2021
Principled selection of baseline covariates to account for censoring in randomized trials with a survival endpointKelly Van Lancker, Oliver Dukes, Stijn Vansteelandt
Epidemiology (Cambridge, Mass.)|April 14, 2018
Eliminating Survivor Bias in Two-stage Instrumental Variable EstimatorsStijn Vansteelandt, Stefan Walter, Eric Tchetgen Tchetgen
Biostatistics (Oxford, England)|November 23, 2017
Instrumental variables estimation under a structural Cox modelTorben Martinussen, Ditte Nørbo Sørensen, Stijn Vansteelandt
Psychometrika|May 19, 2021
Robust Inference for Mediated Effects in Partially Linear ModelsOliver Hines, Stijn Vansteelandt, Karla Diaz-Ordaz
Pharmaceutical Statistics|April 6, 2020
Improving interim decisions in randomized trials by exploiting information on short-term endpoints and prognostic baseline covariatesKelly Van Lancker, An Vandebosch, Stijn Vansteelandt
Biometrical Journal. Biometrische Zeitschrift|July 11, 2021
Efficient, doubly robust estimation of the effect of dose switching for switchers in a randomized clinical trialKelly Van Lancker, An Vandebosch, Stijn Vansteelandt
Biometrics|June 23, 2023
Ensuring valid inference for Cox hazard ratios after variable selectionKelly Van Lancker, Oliver Dukes, Stijn Vansteelandt
Pageof 19

Showing results (51-60 of 184) with videos related to

Sort By:
Pageof 19
Statistics in Medicine|December 6, 2014
Increasing the power of the Mann-Whitney test in randomized experiments through flexible covariate adjustmentKarel Vermeulen, Olivier Thas, Stijn Vansteelandt
Pharmacoepidemiology and Drug Safety|November 26, 2025
All Lines Is the Right Approach: Selecting Patient Lines of Therapy for an External Comparator ArmDaniel Backenroth, Laura Hester, Stijn Vansteelandt
Epidemiology (Cambridge, Mass.)|February 6, 2019
Adjusting the Effect of Integrating Antiretroviral Therapy and Tuberculosis Treatment on Mortality for Noncompliance: A Time-varying Instrumental Variables AnalysisNonhlanhla Yende-Zuma, Henry Mwambi, Stijn Vansteelandt
Statistics in Medicine|May 12, 2021
Principled selection of baseline covariates to account for censoring in randomized trials with a survival endpointKelly Van Lancker, Oliver Dukes, Stijn Vansteelandt
Epidemiology (Cambridge, Mass.)|April 14, 2018
Eliminating Survivor Bias in Two-stage Instrumental Variable EstimatorsStijn Vansteelandt, Stefan Walter, Eric Tchetgen Tchetgen
Biostatistics (Oxford, England)|November 23, 2017
Instrumental variables estimation under a structural Cox modelTorben Martinussen, Ditte Nørbo Sørensen, Stijn Vansteelandt
Psychometrika|May 19, 2021
Robust Inference for Mediated Effects in Partially Linear ModelsOliver Hines, Stijn Vansteelandt, Karla Diaz-Ordaz
Pharmaceutical Statistics|April 6, 2020
Improving interim decisions in randomized trials by exploiting information on short-term endpoints and prognostic baseline covariatesKelly Van Lancker, An Vandebosch, Stijn Vansteelandt
Biometrical Journal. Biometrische Zeitschrift|July 11, 2021
Efficient, doubly robust estimation of the effect of dose switching for switchers in a randomized clinical trialKelly Van Lancker, An Vandebosch, Stijn Vansteelandt
Biometrics|June 23, 2023
Ensuring valid inference for Cox hazard ratios after variable selectionKelly Van Lancker, Oliver Dukes, Stijn Vansteelandt
Pageof 19